Enzo Life Sciences Exendin-4 GLP-1 receptor agonist
Exendin-4 is a 39 aa polypeptide and incretin mimetic which was first isolated from Gila monster saliva. The synthetic form, Exenatide, is a glucagon like peptide-1 (GLP-1) agonist approved for the treatment of diabetes mellitus type II.
Research shows Exendin-4 is involved in glucose-dependent enhancement of insulin secretion, reduction of hyperglycemia, glucose-dependent suppression of inappropriately high glucagon secretion, slowing of gastric emptying and reduction of food intake, often with body weight reduction or blunting of weight gain.
Phone: 02 4575 0309
Antibodies Inc recombinant antibodies
Recombinant chimeric antibodies are designed to offer several advantages beyond easy multiplexing.
Bioss Multiplex Fluorescent IHC Staining Kit
The Bioss Multiplex Fluorescent (5 Colors) IHC Staining Kit enables the simultaneous detection of...
AdipoGen immune checkpoint reagents for immuno-oncology research
AdipoGen Life Sciences offers a broad panel of immune checkpoint reagents, including recombinant...
Learn More
I am interested in Enzo Life Sciences Exendin-4 GLP-1 receptor agonist.
Complete the form and a supplier representative will be in touch.
